Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Anova Innovation Limited

Clinical trials sponsored by Anova Innovation Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for pancreatic cancer: targeted drug combo enters human trials Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for pancreatic cancer: targeted drug combo enters human trials

Disease control Recruiting now

This study tests a new biologic drug called ANO31905 combined with standard chemotherapy as a first treatment for people with advanced pancreatic cancer that has a specific marker (CLDN18.2). The trial has two phases: first to find a safe dose, then to see if the combination shri…

Phase 1/2 • Sponsor: Anova Innovation Limited • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC